Clinical Trials
All Clinical Trials - Page 6 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06727331Phase 2Recruiting
Study of Tirzepatide for Recovery and Alcohol Use Management
Tirzepatide
- NCT07188545N/AActive Not Recruiting
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Tirzepatide
- NCT07165158Phase 4Not Yet Recruiting
The Effect of Semaglutide on Bone Health
Semaglutide
- NCT07035704N/ANot Yet Recruiting
Prevent and Reverse Obesity in Children, Adolescents and Young Adults
Semaglutide
- NCT07152756N/ANot Yet Recruiting
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
Semaglutide
- NCT07156591N/ANot Yet Recruiting
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
Semaglutide
- NCT07153471Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Orforglipron
- NCT07152730Phase 1Withdrawn
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Gonadorelin
- NCT07169136N/ARecruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Semaglutide
- NCT07091734Phase 2Recruiting
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Tirzepatide
- NCT07314684Phase 4Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
Semaglutide
- NCT07171723Phase 1/Phase 2Recruiting
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Semaglutide
- NCT07099742N/ANot Yet Recruiting
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
Tirzepatide
- NCT07139548Phase 3Not Yet Recruiting
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
Semaglutide
- NCT07141914N/ACompleted
A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
Semaglutide
- NCT07115069N/ARecruiting
Comparison of Body Composition Changes With Weight Loss Interventions
Tirzepatide
- NCT07081178N/ATerminated
A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
Semaglutide
- NCT06885736N/ARecruiting
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Tirzepatide
- NCT07621419N/ARecruiting
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
Semaglutide
- NCT07319286Phase 1/Phase 2Enrolling By Invitation
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
Dulaglutide
- NCT07513168Phase 4Recruiting
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
Semaglutide
- NCT07096739N/ACompleted
Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1
Semaglutide
- NCT06073184Phase 2Not Yet Recruiting
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
Tirzepatide
- NCT07096908Phase 4Recruiting
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Tirzepatide
- NCT06903923Phase 2Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Semaglutide
- NCT07073417Phase 2Active Not Recruiting
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Semaglutide
- NCT07071974Phase 1Completed
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
Survodutide
- NCT07097259Phase 1Completed
A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
Gonadorelin
- NCT07065539N/ANot Yet Recruiting
GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients
Gonadorelin
- NCT06867835Phase 4Completed
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
PT-141
- NCT06554717Phase 2Recruiting
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Tesamorelin
- NCT06953882Phase 2Recruiting
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
Gonadorelin
- NCT06861439Phase 4Active Not Recruiting
GLP-1s to Enhance Lasting Optimal Weight
Tirzepatide
- NCT07064486Phase 3Recruiting
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Semaglutide
- NCT06759701EARLY_Phase 1Recruiting
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Tirzepatide
- NCT07042672N/ARecruiting
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
Tirzepatide
- NCT07041983N/AEnrolling By Invitation
24-h Energy Expenditure and Anti-obesity Medication
Tirzepatide
- NCT07087795Phase 1Active Not Recruiting
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
Semaglutide
- NCT07030621Phase 3Not Yet Recruiting
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
Semaglutide
- NCT06937749Phase 2Recruiting
A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Mazdutide
- NCT06934642EARLY_Phase 1Recruiting
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Tirzepatide
- NCT06937099Phase 3Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Tirzepatide
- NCT06937086Phase 3Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Tirzepatide
- NCT07101939Phase 2Recruiting
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
Semaglutide
- NCT06924697N/AEnrolling By Invitation
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
Semaglutide
- NCT07239570Phase 4Recruiting
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Semaglutide
- NCT06852391Phase 4Recruiting
JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
Semaglutide
- NCT07000955Phase 1/Phase 2Active Not Recruiting
Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
Tirzepatide
- NCT07225829Phase 2Recruiting
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
Liraglutide
- NCT07010432Phase 1Recruiting
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Semaglutide